Exelixis

EXEL

EXEL
Exelixis Stock Quote
$21.23 $0.46 2.2%
Price as of February 18, 2020, 4:30 p.m. EST View Interactive EXEL Charts

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

Interactive Chart


News & Analysis: Exelixis

The Fool has written over 500 articles on Exelixis.

All

Market Moves

Podcasts

Earnings




Can Investors Excel in 2020 With Exelixis?

This pharma stock can look forward to a year with more readouts, potential approvals, and new clinical assets providing value in the oncology space.